Karnataka Defends Closure of Jan Aushadhi Kendras in Govt Hospitals

Bengaluru, August 7, 2025 — Karnataka Health Minister Dinesh Gundu Rao has defended the state government’s decision to discontinue Jan Aushadhi Kendras (JAKs) within government hospital premises. His explanation came in response to concerns raised by Union Health Minister J.P. Nadda regarding access to affordable medicines through this central scheme.

 

According to Minister Rao, the move aims to ensure patients receive free and guaranteed essential medicines from public hospitals’ own supplies, eliminating the risk of being directed elsewhere for drug purchases. Doctors are now instructed to prescribe only drugs that are part of the Essential Medicines List (EML) and available in the hospital stock, supplied via the http://Karnataka State Medical Supplies CorporationKarnataka State Medical Supplies Corporation (KSMSCL). Funds are allocated for additional local procurement, if needed.

 

Rao clarified that this change applies only to JAKs located within hospital campuses. Over 1,417 Jan Aushadhi Kendras still operate elsewhere in Karnataka, with only 184 previously located inside hospitals, which have now been phased out. Citizens may continue accessing JAKs outside government premises.

Rao emphasized Karnataka’s commitment to improving public health infrastructure, ensuring rational drug usage, and strengthening medical supply chains—all to benefit underprivileged and marginalized patients.

While acknowledging the affordability of medicines through the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP)—which offers generics at 50–80% lower prices—Rao requested the Pharma and Medical Bureau of India (PMBI) to supply medicines to the Karnataka Health Department at the same rates offered to JAKs, bolstering the state’s free drug supply efforts.

 

Rao emphasized Karnataka’s commitment to improving public health infrastructure, ensuring rational drug usage, and strengthening medical supply chains—all to benefit underprivileged and marginalized patients.

Related Posts

Licences of 20 medical stores suspended after inspections

Drug Control Department inspects 120 medical stores; 32 NDPS cases and 63 arrests recorded in 2026 so far The district administration has intensified action against illegal drug sale and distribution,…

Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

NEW DELHI: Global investment firm Bain Capital has divested nearly a 1 per cent stake in Emcure Pharmaceuticals for over Rs 289 crore through open market transactions, according to the…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Licences of 20 medical stores suspended after inspections

Licences of 20 medical stores suspended after inspections

Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

HP accounts for 47 inferior drugs in March alert

HP accounts for 47 inferior drugs in March alert

Civil society group SAM calls for greater transparency involving clinical trials

Civil society group SAM calls for greater transparency involving clinical trials

Different packaging, typos expose fake Mounjaro racket

Different packaging, typos expose fake Mounjaro racket